ZKSCAN3 and plasma cell myeloma: ZKSCAN3 expression is elevated in various organ cancers, including colon, prostate, bladder, breast, cervix, stomach, myeloma, and liver cancers, and is frequently associated with unfavorable prognostic outcomes [18,21,22,37,38,39,40,41,42].